Clinical Trial Update: Efficacy and Safety of Camrelizumab Combined With Nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial assessing camrelizumab with nab-paclitaxel and gemcitabine for metastatic pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Camrelizumab (camrelizumab)
• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Fudan University | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: UNKNOWN